IPO Report: Third Point Reinsurance Ltd. (TRPE)

Francis Gaskins |

Three other IPOs were scheduled for the week of August 12. The full IPO calendar can be found at IPOpremium.

Third Point Reinsurance Ltd. ($TRPE) is based in Bermuda and scheduled a $300 million IPO with a market capitalization of $1.36 billion, at a price range mid-point of $13.50, for Thursday, August 15, 2013.

The price-range S-1 was filed August 5, 2013.  The manager and joint managers are: J.P. Morgan; Credit Suisse; Morgan Stanley; BofA Merrill and Citigroup.  The co-managers are Aon Benfield Securities; Dowling & Partners; Keefe, Bruyette & Woods (A Stifel Company); Macquarie Capital; Sandler O'Neill + Partners.


TRPE is a relatively new Bermuda-based property and casualty reinsurer. TRPE began operations January 1, 2012.

Because TRPE is new, it has a clean balance sheet, no debt and limited legacy liabilities, meaning no opportunity for surprise reserve increases.

For the six months ended June 30, 2013 net income was $112, which includes investment income of $112 million. In July TRPE generated $28 million in investment income.

TRPE has a very experienced management team.


Newer property and casualty companies start out with a high combined ratio (lower is better). TRPE's combined ratio for the six months ended June, 2013 is 108%. All of TRPE's income for the six months ended June 30, 2013 is from investments, managed by a large hedge fund on an outsourced basis.

The outsourced hedge fund investment return seems quite high, and was perhaps somehow created to assist TRPE's IPO. The hedge fund's manager is also a shareholder of TRPE.

Valuation Ratios


Price /

Price /

Price /

Price /

% offered

annualizing June 6 mos '13

Cap (MM)





in IPO

Third Point Reinsurance Ltd. (TRPE)









Neutral to negative because more than all the profits for the 6 months ended June 30, 2013 came from 'investments', which are managed by a relatively large hedge fund on an outsourced basis.

One of the hedge fund's officers is also a shareholder in TRPE...which begs the question of whether those outsized investment profits were 'manufactured' to help the IPO.


TRPE is a Bermuda-based property and casualty reinsurer with a reinsurance and investment strategy that TRPE believes differentiates it from competitors.

Substantially all of TRPE's investable assets are managed by its investment manager, Third Point LLC, which is wholly owned by Daniel S. Loeb, one of the founding shareholders. Third Point LLC is an SEC-registered investment adviser headquartered in New York, managing $13.2 billion in assets as of June 30, 2013.

TRPE starting writing insurance January 1 2012, and has an A.M. Best rating of A-.


TRPE was incorporated on October 6, 2011 and completed its initial capitalization transaction on December 22, 2011 with $784.3 million of equity capital, and commenced underwriting business on January 1, 2012. In January 2012, TRPE received an A- (Excellent) financial strength rating from A.M. Best Company, Inc., or A.M. Best.

11% return (not annualized) on equity for period ended June, 2013; 13% annualized return since January 2012.

Third Point LLC

TRPE's assets are held in a separate account and managed by Third Point LLC on substantially the same basis as its main hedge funds, including Third Point Partners L.P., the original Third Point LLC hedge fund.


TRPE's management team is led by John R. Berger, a highly-respected reinsurance industry veteran with over 30 years of experience, the majority of which was spent as the principal executive officer of three successful reinsurance companies.

In addition, TRPE recruited a management team around Mr. Berger that also has significant senior leadership and underwriting experience in the reinsurance industry.

5% shareholders before IPO

KIA TP Holdings, L.P., 33.15%
KEP TP Holdings, L.P., 33.15
Pine Brook LVR, L.P., 16.76%
Daniel S. Loeb, 10.75%
P RE Opportunities Ltd., 6.75%

Use of proceeds

TRPE expects to net $267 million from its IPO.

TRPE expects to contribute substantially all the net proceeds to its subsidiary's (Third Point Re)'s surplus to increase underwriting capacity in order to support the growth of reinsurance premium writings.


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.


EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more


MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…